Press Releases

Mithra Issues a Put Option Notice Under Capital Agreement with LDA Capital
13 May 2022
EN FR

Presentation of Donesta® Phase 3 Topline Efficacy Results at the 20th ISGE World Congress
12 May 2022
EN FR

Publication of a Transparency Notification Received from Glenernie Capital
6 May 2022
EN FR

Publication of Transparency Notifications Received from Goldman Sachs
29 April 2022
EN FR

Mithra CDMO Announces Collaboration with MedinCell for the Development of Injectable Products for Malaria and Transplant Rejection
26 April 2022
EN FR

Information on the Total Number of Voting Rights (denominator) following Exercise of a Call Option from Goldman Sachs
20 April 2022
EN FR

Mithra Releases Invitation to its General Ordinary and Extraordinary Securities holders’ Meeting
19 April 2022
EN FR

Mithra Announces the Extension of the Capital Commitment Agreement with LDA Capital by Two Years and the Increase of the Commitment by EUR 25 million
18 April 2022
EN FR

Mithra Releases 2021 Annual Report
15 April 2022
EN FR

Mithra Announces Improved Consolidated Topline Results from Donesta® Phase 3 Studies and Launch of Recruitment for the Extension of European Study
14 April 2022
EN FR

Publication of a Transparency Notification Received from Goldman Sachs
8 April 2022
EN FR

Publication of a Transparency Notification Received from François Fornieri
29 March 2022
EN FR